These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 17320042

  • 1. Action mechanism of tachyplesin I and effects of PEGylation.
    Imura Y, Nishida M, Ogawa Y, Takakura Y, Matsuzaki K.
    Biochim Biophys Acta; 2007 May; 1768(5):1160-9. PubMed ID: 17320042
    [Abstract] [Full Text] [Related]

  • 2. Action mechanism of PEGylated magainin 2 analogue peptide.
    Imura Y, Nishida M, Matsuzaki K.
    Biochim Biophys Acta; 2007 Oct; 1768(10):2578-85. PubMed ID: 17662233
    [Abstract] [Full Text] [Related]

  • 3. Deletion of all cysteines in tachyplesin I abolishes hemolytic activity and retains antimicrobial activity and lipopolysaccharide selective binding.
    Ramamoorthy A, Thennarasu S, Tan A, Gottipati K, Sreekumar S, Heyl DL, An FY, Shelburne CE.
    Biochemistry; 2006 May 23; 45(20):6529-40. PubMed ID: 16700563
    [Abstract] [Full Text] [Related]

  • 4. Interactions of an antimicrobial peptide, tachyplesin I, with lipid membranes.
    Matsuzaki K, Fukui M, Fujii N, Miyajima K.
    Biochim Biophys Acta; 1991 Nov 18; 1070(1):259-64. PubMed ID: 1751532
    [Abstract] [Full Text] [Related]

  • 5. Effects of PEGylation on the binding interaction of magainin 2 and tachyplesin I with lipid bilayer surface.
    Han E, Lee H.
    Langmuir; 2013 Nov 19; 29(46):14214-21. PubMed ID: 24160865
    [Abstract] [Full Text] [Related]

  • 6. Mechanism of tachyplesin I injury to bacterial membranes and intracellular enzymes, determined by laser confocal scanning microscopy and flow cytometry.
    Hong J, Guan W, Jin G, Zhao H, Jiang X, Dai J.
    Microbiol Res; 2015 Jan 19; 170():69-77. PubMed ID: 25267486
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Specific interactions of the antimicrobial peptide cyclic beta-sheet tachyplesin I with lipopolysaccharides.
    Hirakura Y, Kobayashi S, Matsuzaki K.
    Biochim Biophys Acta; 2002 May 03; 1562(1-2):32-6. PubMed ID: 11988219
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Influences of disulfide connectivity on structure and antimicrobial activity of tachyplesin I.
    Shi J, So LY, Chen F, Liang J, Chow HY, Wong KY, Wan S, Jiang T, Yu R.
    J Pept Sci; 2018 Jun 03; 24(6):e3087. PubMed ID: 29870123
    [Abstract] [Full Text] [Related]

  • 19. Interaction of a novel antimicrobial peptide isolated from the venom of solitary bee Colletes daviesanus with phospholipid vesicles and Escherichia coli cells.
    Čujová S, Bednárová L, Slaninová J, Straka J, Čeřovský V.
    J Pept Sci; 2014 Nov 03; 20(11):885-95. PubMed ID: 25123582
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.